Menu
+
+
+
+
+
+
Ocera said it received CE Mark approval for Zysa to treat diarrhea-predominant irritable bowel syndrome (IBS-D). The product is marketed in Asia as Kremezin...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
